JPMorgan Chase & Co’s Pasithea Therapeutics KTTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108 | Hold |
150
| – | – | ﹤0.01% | 5940 |
|
|
2025
Q1 | $195 | Hold |
150
| – | – | ﹤0.01% | 5925 |
|
|
2024
Q4 | $473 | Hold |
150
| – | – | ﹤0.01% | 5755 |
|
|
2024
Q3 | $813 | Hold |
150
| – | – | ﹤0.01% | 5675 |
|
|
2024
Q2 | $785 | Hold |
150
| – | – | ﹤0.01% | 5620 |
|
|
2024
Q1 | $1.1K | Hold |
150
| – | – | ﹤0.01% | 5628 |
|
|
2023
Q4 | $1.11K | Hold |
150
| – | – | ﹤0.01% | 5786 |
|
|
2023
Q3 | $1.44K | Hold |
150
| – | – | ﹤0.01% | 5637 |
|
|
2023
Q2 | $1.47K | Hold |
150
| – | – | ﹤0.01% | 5485 |
|
|
2023
Q1 | $1K | Hold |
150
| – | – | ﹤0.01% | 5656 |
|
|
2022
Q4 | $2K | Buy |
150
+100
| +200% | +$1.33K | ﹤0.01% | 5370 |
|
|
2022
Q3 | $1K | Hold |
50
| – | – | ﹤0.01% | 5417 |
|
|
2022
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 5489 |
|
|
2022
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 5645 |
|
|
2021
Q4 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 5595 |
|